-+ 0.00%
-+ 0.00%
-+ 0.00%

Xenetic Biosciences Q4 EPS $(0.68) Misses $(0.20) Estimate, Sales $648.82K Beat $230.00K Estimate

Benzinga·03/19/2025 12:26:45
Listen to the news
Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.20) by 240 percent. This is a 188.31 percent decrease over earnings of $0.77 per share from the same period last year. The company reported quarterly sales of $648.82 thousand which beat the analyst consensus estimate of $230.00 thousand by 182.10 percent. This is a 3.44 percent decrease over sales of $671.96 thousand the same period last year.